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Approaches to Assessing Host
Resistance
by S. Gaylen Bradley* and Page S. Morahan*
There is increasing evidence that chronic, subclinical exposure to certain environmental
pollutants may upset immune responsiveness and alter susceptibility of animals to infectious
agents. Environmental chemicals or drugs may affect diverse aspects of the immune system,
leading to immunosuppression, immunopotentiation, hypersensitivity or perturbed innate host
resistance. A variety ofinfectious models is available that involves relatively well defined target
organs and host defense mechanisms; for example, infections with encephalomyocarditis virus,
Herpesvirus simplex, Listeria monocytogenes, Streptococcus pneumoniae, Escherichia coli or
Plasmodium berghei. Important variables in infectious models used to assess immunotoxicity
include species and strain of animal used, their age and sex, the route of exposure, and dose of
the chemical. No one infectious model has yet emerged as a routine screening tool to detect and
assess the subtle effects that may occur in immune responses when animals are exposed to
doses of environmental pollutants that cause no adverse effect at a gross level. The selection of
useful test systems is complicated because it is difficult to measure the effects of chronic,
subclinical exposure to chemicals and sublethal challenges of microorganisms.
Introduction
Chronic, subclinical exposure to certain envi-
ronmental pollutants or drugs may perturb immune
responsiveness and alter susceptibility of animals
to infectious agents. Environmental chemicals or
drugs may affect diverse aspects of the immune
system, leading to immunosuppression, immuno-
potentiation, perturbed innate host resistance and
hypersensitivity. A variety of experimental meth-
ods are being developed and evaluated in order to
assess changes in host resistance following exposure
to chemicals. Particular aspects of the vast array
of cellular products and cell types involved in
immunity can be examined selectively in appropriate
models for monitoring host resistance in whole
animals. Many ofthe complexities attendant to the
effects of chemicals on immunologic processes,
however, are unresolved. It is timely, therefore,
to ask whether infectious models can be used
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routinely to assess immunotoxicity, what their
reliability is, and whether they have utility in
predicting human risk.
There is evidence that exposure to environmen-
tal pollutants causes alterations in various immune
responses. Our colleagues have shown, for exam-
ple, that polychlorinated biphenyls, chloroform
and trichloroethylene administered orally to mice
for 90 days lead to immunosuppression of some
immune responses (1-4). In addition, Vos (5) and
Koller (6) have reviewed some results with other
chemicals. There is considerable difficulty in inter-
preting data from different laboratories however.
This complexity arises in large part from the rapid
proliferation of information and methodology in
the field of immunology. Moreover, the protocols
used to measure immune functions and the meth-
ods for calculating and reporting data may be quite
dissimilar for different laboratories. In order to
resolve this dilemma, it is necessary to develop a
battery ofstandard assays that can be reproducibly
used in different laboratories. Other reasons for
inconsistency in results stem from the differences
61Table 1. Important variables in assessing host resistance.
Variable Routine screening In-depth study
Strain One strain Many strains
Sex One sex Both sexes
Age Young adult Weanling to aged
Exposure period Subehronic - 14 days Subchronic - 90 days
Exposure route Intraperitoneal Several routes
Exposure relative to challenge Pre- and post-challenge Only before or only after challenge
in animals used (species, strain), in sex, in age
(neonatal, weanling, young adult, adult, aged) and
finally differences in exposure to the chemical
under study (administration before, during or both
before and during challenge) (Table 1). In an
in-depth study, it may be necessary to use a
number of strains because of genetically deter-
mined differences. Male and female animals may
vary in their handling of a chemical. Weanling or
aged animals may be more susceptible to im-
munotoxicologic effects because such animals are
somewhat immunodeficient. Long exposure peri-
ods may be necessary because definitive organ site
toxicity may not be manifested within a shorter
period, such as 14 days. Exposure by inhalation,
oral administration or dermal contact may be a
more appropriate model for assessing the effects of
environmental exposure thanintraperitoneal admin-
istration.
Effects of Chemicals on Infectious
Organisms in Animals
A growing number of reports on adverse effects
of environmental chemicals on host resistance to
various infections in animals have appeared during
the past decade. Some of these are summarized in
Table 2. Virus infections, especially with encepha-
lomyocarditis virus, have been the most studied.
Interpretation of results from studies using infec-
tious models is even more difficult than those using
immunologic assays. Several species as well as
different strains of animals have been used, in
addition to male and female animals, different
ages, different routes of exposure to the chemical
(parenteral, oral), and different timing regimens
(acute, chronic). These variables have also been
confounded by using a variety ofinfectious agents,
for which the pathogenesis and host resistance
parameters have been fully established in only a
few instances.
We have previously shown that treatment intra-
peritoneally with some immunomodulators changes
host resistance to Herpesvirus simplex locally but
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has no effect systemically (34). Similar differences
have been observed recently between local and
systemic effects in mice fed a high fat diet and
given immunomodulator intraperitoneally before
Listeria infection. The liver and its macrophages
proved to be the target most adversely affected by
the high fat diet, while the fixed macrophages in
the peritoneal cavity were normally activated after
immunomodulator treatment (Campbell and Loria,
unpublished results). These data emphasize the
importance ofseparating local from systemic effects,
and the necessity of using microbial infections for
which the pathogenesis and immune responses
have been well characterized. The standard toxic-
ity parameters of lymphoid organ weight, and
hematologic profiles are also important in interpre-
ting any changes in host resistance properly.
Potentially Useful Viral Models
Infection with the picornavirus, encephalomyo-
carditis virus (EMC), has been used extensively in
immunotoxicologic studies. This picornavirus pro-
duces a rapid systemic illness in mice, particularly
in the heart and brain target organs. Systemic
infection by EMC is one of the standard infections
used to assess efficacy of antiviral therapy (35).
Host defense mechanisms involved in recovery
from this infection have been extensively docu-
mented; they include an early interferon response
and induction of systemic neutralizing antibody
which is independent of T-lymphocytes in the
primary response (36, 37). Studies on depletion of
macrophages in infection with another picornavi-
rus, Coxsackievirus, have indicated a role for
these cells, possibly in an antibody-dependent
cell-mediated cytotoxicity (ADCC) reaction which
would amplify the viral specific antibody (36).
Resistance to this virus is not markedly age
related, but there are differences between the
sexes in some mouse strains (38). Genetic resis-
tance has not been as extensively studied as for
some other virus infections. The primary impor-
tance of antibody in resistance to another picorna-
Environmental Health PerspectivesTable 2. Microbial infections used to assess changes in host resistance upon exposure of animals to environmental chemicals.
Microorganisms Chemical Animal Reference
Viruses
Herpesviruses
Pseudorabies virus
Herpesvirus simplex
Enteroviruses
Duck hepatitis virus
Encephalomyocarditis virus
Arboviruses
St. Louis encephalitis
Eastern encephalitis virus
Langat virus
Myxoviruses
Influenza virus
Retroviruses
Moloney leukemia virus
Rauscher leukemia virus
Bacteria
Salmonella bern
Salmonella typhimurium
Listeria monocytogenes
Escherichia coli
Staphylococcus epidermidis
Staphylococcus sp.
Mycobacterium bovis
Parasites
Hexamita muris
Plasmodium berghei
Histomonas meleagridis
Heligmosomoides polygyrus bakeri
Arsenicals
TCDD
Cannabis
PCB
Dieldrin
DDT
PCB
Toximul MP88 and Atlox 3409 emulsifiers, DDT
Arsenicals
Cobalt sufate
Cadmium, mercury, lead nickel
Methylmercury
Lead
Arsenicals
Arsenicals
Lead
Sulfur dioxide
PCB
Arsenicals
Methylmercury
Lead
TCDD
Lead
Cannabis
PCB
Lead
Cadmium
Lead
Sevin, Dicresyl, Jalan Tilliam, Maneb
Cadmium
Cadmium
PCB, HCB
p,p'-DDT
DDT
Mice
Mice, C57BL/6Jth
Mice, BALB/c
Mice, Swiss ICR
Mallards
Mallards
Mallards
Mice, Swiss ICR
Mice
Mice
Mice, CD-1
Mice, Swiss-Webster
Mice, Swiss-Webster
Mice
Mice
Mice
Mice, Swiss-Webster
Mice, BALB/c
Mice
Mice, BALB/c
Mice
Mice, C57BL/6Jth
Mice, Swiss-Webster
Mice, BALB/c
Mice, Swiss ICR
Rat
Mice
Rat
Rat
Mice, B10-A-2R
Mice, Swiss-Webster
Mice, BALB/c
Chickens
Mice
virus, echovirus, has also been well documented in
patients with agammaglobulinemia (39).
Although treatment with an environmental con-
taminant may reduce various immune responses
such as antibody production, it does not inevitably
decrease host resistance. In an experiment in
which mice were administered trichloromethane
by gavage for 14 days, there was no significant
change in the delayed hypersensitivity response to
sheep erythrocytes nor was there a significant
decrease in resistance to EMC virus (Table 3).
Serum antibody titers to sheep erythrocytes how-
ever were decreased by 63% and 85% with doses
of 50 and 250 mg/kg, respectively, in female mice,
and by 70% and 79%, respectively, in male mice.
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Another infectious agent that may prove useful
in immunotoxicity is Herpesvirus simplex (HSV).
We and others have clearly documented the multi-
faceted aspects of the immune response that may
be involved in resistance to HSV infections (40,
41). Sensitization of T-lymphocytes, with subse-
quent activation ofmacrophages for antiviral activ-
ity, appears to be prominent in host resistance.
Whether the same types of macrophages or mac-
rophage functions are involved in antibacterial,
antiviral and antitumor resistance is as yet unclear.
We have shown that antiviral and antitumor func-
tions of macrophages do not necessarily occur
simultaneously (42). A role for interferon in the
early stages of infection has been documented by
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(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14-17)
(7)
(18)
(19)
(20)
(21)
(7)
(7)
(22)
(23)
(24)
(7)
(20)
(25)
(8)
(26)
(9)
(10)
(27)
(27)
(27)
(28)
(29)
(30)
(31)
(32)
(33)Table 3. Effects oftrichloromethane on resistance to enceph-
alomyocarditis (EMC) virus and the immune response to
sheep erythrocytes (sRBC).a
Treatment, Anti-sRBC Log LD50 (95%
mg/kg titer confidence limits)
None 3401 t 403 7.2 (6.0-8.0)
Vehicle 5295 t 808 6.9 (6.2-7.6)
5 4040 t 318 6.7 (6.1-7.3)
50 1960 t 234 7.5 (6.5-8.4)
250 820 t 225 6.4 (6.0-6.9)
aSix-week-old female ICR mice weregavaged dailyfor 14days
with the indicated doses and then challenged intravenously with
dilutions of encephalomyocarditis virus, and the LD50 deter-
mined. Mortality was measured over a 14-day period. Separate
groups ofmice were immunized with sheep erythrocytes on day
8 of exposure. Serum was collected on day 15 and serum
antibody titers were determined. Each anti-sRBC value repre-
sents the mean t standard error of the reciprocal of the titer,
based upon 8 mice per group.
showing decreased resistance to HSV in mice
treated with anti-interferon serum (43). Recently,
a role for natural killer (NK) cells and for activated
macrophages has been demonstrated for the early
stages of infection (44). The induction of the
T-cell-dependent neutralizing antibody does not
appear to be of primary importance in the initial
reduction of virus, but may be involved in recov-
ery and altering the latent infection with HSV
which often follows primary infection (45). Very
small amounts of antibody may be amplified tre-
mendously (several magnitudes) by the ADCC
reaction (46); thus antibody in conjunction with
mononuclear phagocytes may also be involved in
recovery from primary infection. The presence of
neutralizing antibody is sufficient to protect mice
from a second challenge with the virus (47). HSV
infection will thus monitor the adequate function-
ing of many elements in the immune system:
interferoninduction, T-lymphocytes, B-lymphocytes,
NK cells and macrophages. For these reasons, we
believe that HSV infection may be a very sensitive
indicator of changes in any aspect of the immune
system. We have shown, for example, that depres-
sion ofeither macrophage function orT-lymphocytes
markedly reduces resistance to this virus (40).
Another potential advantage of this virus infec-
tion is that different pathogeneses of infection and
induction of immune responses occur with differ-
ent routes of inoculation (47, 48). A local infection
resulting in vesicles can be observed clinically
after labial or vaginal inoculation of HSV. More-
over, HSV often becomes latent in the sensory
ganglia in survivors of infection and the incidence
of latency can be markedly altered by changes in
the immune responses of the animal (45). The
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latent virus can be reactivated by immunosuppres-
sion (49). The labial infection is particularly advan-
tageous in all of these respects (local infection,
systemic immune responses, latency in the easily
accessible trigeminal ganglion, alteration oflatency
by immune responses and reactivation of latent
virus).
There is clear evidence for genetic resistance to
HSV. C57BL/6 mice are among the most resistant,
and resistance is dominant (50). The mechanism of
resistance has not been completely defined; Lopez's
present hypothesis is that a marrow dependent
cell, possibly the NK cell, is involved. We and
others have also documented that resistance to
HSV also increases considerably with the age of
mice (40).
Potentially Useful Bacterial
Models
Infectionwiththegram-positivebacteriumListeria
monocytogenes has been extensively investigated
in regard to pathogenesis of infection, and the
immune responses that are involved in recovery of
animals from infection. From the data reported in
the series of elegant studies of Mackaness and
colleagues at the Trudeau Institute (51, 52), it is
now well accepted that recovery from infection
depends upon specific sensitization ofT-lymphocytes
that then activate macrophages for enhanced
nonspecific bactericidal activity. Fixed macrophages
are also involved in the initial inactivation of the
bacterium, while the activation of macrophages
occurs within 2-3 days following systemic infec-
tion. Resistance to the bacterium can be assessed
by mortality, or by bacterial colony counts of the
liver and spleen, which are major sites for replica-
tion ofthe bacteria.
The resistance of mice to Listeria can be pro-
foundly altered by the genetic makeup of the
animal. For example, the C57BL/6 mouse is resis-
tant, while the A mouse is susceptible (53). The
mechanism of the genetic resistance is as yet
unclear. Bone marrow studies have indicated that
resistance is determined by the host rather than
by the donor, and that the spleen of the resistant
animal is required for expression of the genetic
resistance. The current hypothesis is that genetic
resistance involves an interaction between macro-
phages and the microenvironment provided by the
resistant genotype (54). Despite the complexity of
these interactions, Listeria infection provides a
reliable model that has been well characterized.
The infection primarily assesses competency of
T-lymphocytes and macrophages.
Environmental Health PerspectivesTable 4. Effects ofcannabinoids on resistance toHerpesvirus
simplex type 2 (HSV-2) and Listeria monocytogenes infec-
tions.
Treatmenta Decrease in resistance tob
Drug Dose, mg/kg Listeria HSV-2
Vehicle --- 2 6
A9-THC 200 365c 96c
Marijuana extract 200 88C 3
Flumethazone 5 385C 101
Cyclophosphamide 200 Not done 260C
aMice were inoculated intravenously with dilutions of each
microorganism and treated intraperitoneally on days 1 and 2
with the indicated doses of drug. The LD50 for HSV-2 was 101 9
(95% confidence limits 101'4 to 1024), expressed as dilution
factors. The LD50 for Listeria was 1052 (95% confidence limits
104.8 to 105-5) colony-forming units. See Morahan et al. (9) for
complete data.
bDecrease in resistance: LD50 for untreated group/LD50 for
treated group.
cSignificantly different from the untreated group at p < 0.05.
We have used both Listeria and HSV infections
to assess host response to environmental toxicants
and drugs. In one study, the effects of treatment
with marijuana extract or with the pure chemical
A9-tetrahydrocannabinol (A9-THC) was compared
with effects oftreatment with the known immuno-
suppressive alkylating agent, cyclophosphamide,
or the steroid flumethazone (Table 4). The stan-
dard immunosuppressive regimens markedly de-
creased resistance to both HSV and Listeria, as
did treatment of mice with A9-THC. The course of
the Listeria infection was also exacerbated by
treatment with marijuana extract but the HSV
infection was not. Although there are certain
similarities in resistance mechanisms to these two
microorganisms, it is clear that there are differ-
ences, too (9).
In another study, mice were exposed by gavage
to polychlorinated biphenyls (Aroclor 1254) daily
for 14 days prior to infection with Listeria or
HSV-2 (Table 5). Whereas treatment with the
known immunosuppressive steroid flumethazone
decreased resistance significantly, there was no
effect with the polychlorinated biphenyl exposure.
This lack of effect on host resistance contrasts
with the marked effect observed with this envi-
ronmental toxicant on standard immune assays.
Serum antibody titers to sheep erythrocytes were
reduced dose dependently to 20% of control values
by 25 mg/kg in male mice and to < 1% of control
values in female mice. The delayed hypersensitiv-
ity response to sheep erythrocytes was completely
abolished in male mice only with the highest dose
tested (75 mg/kg); however, a dose of 12.5 mg/kg
reduced the delayed hypersensitivity response by
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Table 5. Effects of polychlorinated biphenyl (PCB) on resis-
tance toListeria monocytogenes orHerpesvirus simplex type
2 (HSV-2) infections.
Treatmenta Decrease in resistance tob
Drug Dose, mg/kg Listeria HSV-2
PCB vehicle 1 1
PCB 30 3 1
Flumethazone vehicle 2 1
Flumethazone 5 794c 20C
aBALB/c mice were treated for 14 days by gavage with PCB
priorto infection orfortwo days afterinfection byintraperitoneal
administration of flumethazone. Mice were infected intrave-
nously with dilutions of microorganisms. The LD50 for HSV-2
was 1023 (dilution factor) and for Listeria the LD5 was 105-4
colony-fonning units. These data were kindly supplied by
Munson et al. (10).
bDecrease in resistance: LD50 for untreated group/LD50 for
treated group.
cSignificantly different fromthe untreated control atp < 0.05.
40%. Flumethazone at 5 mg/kg administered sub-
cutaneously on days 1, 2 and 3 after antigen
completely suppressed both humoral and cell medi-
ated responses to sheep erythrocytes.
The pathogenesis and immune responses to
Streptococcus pneumoniae infection have been
extensively characterized also. Recovery from infec-
tion depends upon the induction of opsonizing
antibody, which in conjunction with phagocytic
cells, enhances phagocytosis ofS. pneumoniae and
its subsequent intracellular destruction (55-57).
End points of mortality and measurement of anti-
body status (by in vitro methods or rechallenge of
the surviving animals) can be determined. This
classic infection thus measures the function of
B-lymphocytes and plasma cells to produce the
T-cell independent antibody to the pneumococcal
polysaccharide, as well as the functional capacity
of granulocytic, phagocytic cells.
The gram-negative entericbacteriumEscherichia
coli is capable ofcausing avariety ofextraintestinal
infections in man. Virulence of different strains in
intraperitoneal infection of mice correlates well
with virulence in natural infection (58). Mouse
virulence is directly related to survival and multi-
plication in the peritoneal cavity leading to produc-
tion of large amounts of endotoxin (58, 59). The
virulence is correlated with resistance to phagocy-
tosis by both macrophages and polymorphonuclear
phagocytes (58, 59). Phagocytosis can be enhanced
by the presence of opsonins and complement in
normal serum or specific antibody to E. coli K
antigens (58, 60). In the later phases of infection,
survival should be dependent on the animal's
defense against the effects of endotoxin. The
65Table 6. Effects ofchemicals onresistance toliveEscherichia
coli and purified endotoxin.
Treatmenta Decrease in resistance tob
Chemical Dose, mg/kg E. coli cells Endotoxin
None --- 1 1
Actinomycin D 0.4 55C 266c
6-Mercaptopurine 100 55c 23c
A9-Tetrahydro-
cannabinol 150 7c 12C
Vincristine 1 9c 13C
aMale mice were injected intraperitoneally with drug, live E.
coli cells or purified gram-negative bacterial endotoxin as
indicated. The LD50 for actinomycin D was 0.8 mg/kg; for
6-mercaptopurine, 220 mg/kg; for A9-tetrahydrocannabinol, 350
mg/kg; forvincristine, 7mg/kg; forliveE. coli, 5.5 x 109cells/kg;
and for purified E. coli 0127:B8 (Boivin) endotoxin, 16 mg/kg.
bDecrease in resistance: LD50 for untreated group/LD50 for
treated group.
cSignificantly different from the untreated group at p < 0.05.
extraintestinal virulence of a particular E. coli
strain for mice is influenced by the presence and
identity of 0 and K surface antigens, especially Kl
(60).
The susceptibility of animals to gram-negative
bacteria and their endotoxins can be altered dra-
matically by a variety of chemicals (61). We have
studied extensively the enhanced toxicity of gram-
negative bacteria or endotoxin in combination with
drugs for more than a decade. Drugs that inhibit
protein synthesis or ribonucleic acid synthesis
render animals unusually susceptible to live E. coli
or purified endotoxin whereas endotoxin renders
animals particularly vulnerable to the adverse
effects of drugs that affect deoxyribonucleic acid
synthesis, structure or function (61-63). Actinomy-
cin D, 6-mercaptopurine, A9-THC and vincristine,
for example, at sublethal doses impaired the resis-
tance of mice to challenge with live E. coli or
purified endotoxin (Table 6). The extent of the
decrease in resistance with respect to the two
endotoxic sources was similar for each chemical,
affirming that endotoxin has some role in the
pathogenesis of E. coli infections. The interlock
among the actions of the host on the drug, of the
bacterial pathogen and the test chemical on the
host, and of the chemical on the bacteria are
especially complex in E. coli infections (62). Bacte-
rial endotoxin (purified or as gram-negative cells)
impairs the activity of the liver mixed function
oxidases in treated animals. Several chemicals, for
example chlorambucil, are metabolized by these
microsomal enzymes (61-63). Elevated drug levels
resulting from impaired detoxification may retard
the growth of live E. coli if the test chemical has
antimicrobial activity, or they may exacerbate the
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endotoxic action of the gram-negative bacterium
by rendering the host hyperreactive to endotoxin.
A number of chemicals affect the integrity of the
intestinal mucosa, thereby allowing the "endoge-
nous" gram-negative bacteria to gain access into
the circulatory system. Theseinterconnected events
may establish a cycle of adverse effects that
amplify the interaction between a chemical tc;xi-
-cant and an infectious agent.
Potentially Useful Protozoan
Model
Plasmodium berghei, an intracellular sprozoan
parasite causing malaria in a variety of rodents, is
potentially useful in immunotoxicity assessments
(64). Mice and rats infected with p. berghei have
been used extensively as models for examining
immunity and host defense mechanisms in malaria
and as in vivo assays for potential antimalarial
drugs. With highly adapted parasites such as
Plasmodium, a combination ofimmunological effec-
tor mechanisms of host resistance is well recog-
nized. Ingestion and destruction of antibody-
coated or surface-modified Plasmodium and Plas-
modium-infected erythrocytes (by phagocytes in-
cluding macrophages) is thought to be a common
effector mechanism (65, 66).
More information is needed however on the
molecular changes in parasitized erythrocytes at
various stages of Plasmodium development and of
the quantitative aspects of antigenic changes (and
effects of antibody binding). Inhibition of invasion
of erythrocytes by Plasmodium merozoites can be
mediated by antibody (67). Evidence that T-lym-
phocytes may also be involved in resistance comes
from the observation that mediators of nonspecific
resistance, such as BCG organisms, are capable of
affecting parasite elimination in some strains of
mice while nude mice remain highly susceptible
(68).
Conclusions
A variety of infectious models are available that
involve relatively well defined target organs and
host defense mechanisms (Table 7). It appears,
however, that no one infectious model has yet
emerged as a routine screening tool to detect and
assess the subtle toxic effects that may occur in
immune responses when animals are exposed to
doses of environmental pollutants that cause no
adverse effect at a gross level. This conservative
judgement of the current state-of-the-art reflects
both the sophisticated nature of the cellular and
Environmental Health PerspectivesTable 7. Synopsis of selected infectious models potentially useful in immunotoxicity assessments.
Target organs after ID or IV
Organism inoculation Host defense mechanisms assessed primarily
Viruses
Encephalomyocarditis virus Heart, brain Interferon production
Antibody production by B-cells
Herpesvirus simplex Local site of infection Interferon production
Central nervous system T-cells
Macrophages
Natural killer cells
Antibody production by B-cells
ADCC reactiona
Bacteria
Listeria monocytogenes Liver, spleen T-cells
Macrophages
Streptococcus pneumoniae Spleen, liver, lungs, kidneys Opsonizing (T-cell independent) antibody production by B-cells
Antibody dependent phagocytosis and intracellular destruction by
granulocytes
Escherichia coli Peritoneal cavity, liver, spleen Sensitization to endotoxin
Phagocytosis and intracellular destruction by phagocytes
Opsonizing antibody production by B-cells
Complement
Parasite
Plasmodium berghei Erythrocytes, liver, spleen T-cell dependent antibody production by B-cells
Macrophages (ADCC reaction?)
aAntibody-dependent cell-mediated cytotoxicity.
molecular interactions operant in host resistance
and the experimental reality that the optimum
conditions for achieving sensitive and reproducible
predictor systems in immunotoxicology have not
been adequately defined. The selection of useful
test systems will not be achieved easily because it
is difficult to work with models concerned with the
effects of chronic, subclinical exposure to chemi-
cals. This difficulty is compounded when there is
also a need to assess these effects in infection
initiated with sublethal challenges of microorga-
nisms.
It is timely to ask whether infectious models
should be used routinely to assess immunotoxicity,
and which immune dysfunctions cause increased
risk to infectious agents or tumors in humans.
There is no doubt that immunodeficiency in humans
increases risk to infectious diseases. In general
terms, patients with B-cell deficiencies are very
susceptible to bacterial pathogens but have rela-
tively normal resistance to viralinfections. Patients
with T-cell deficiencies are very susceptible to
fungal, protozoan and viral infections and show
increased vulnerability to intracellular bacterial
parasites. Patients with phagocytic dysfunction
are unusually susceptible to bacterial infections
but have relatively normal resistance to viral or
protozoan infections. In light of the increasing
evidence that low levels of environmental pollu-
tants affect the immune system and impair host
resistance to infectious agents (69), it is prudent to
evaluate the utility of selected infectious models in
immunotoxicity assessment.
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